NHS Humber Health Partnership Chooses Dedalus ORBIS for Electronic Patient Records
NHS Humber Health Partnership selects Dedalus ORBIS for electronic patient records. This aims to enhance patient care and staff experience. 📊💻
January 9, 2026
Follow us
latest articles
Discover the newest research about AI innovations in Research.
Cyberspatial privacy in the digital age: a proxemics-based framework with a healthcare application.
Exploring cyberspatial privacy in healthcare: a new framework highlights ethical risks of digital data exposure. 🏥🔒
January 9, 2026
Artificial Intelligence-Assisted Automated DNA Ploidy Analysis of Oral Lesions From Fanconi Anemia Patients With DNA Karyometry.
AI-Enhanced DNA Analysis Boosts Oral Lesion Detection in Fanconi Anemia: 84% Sensitivity Achieved! 📊🧬
January 9, 2026
Cera Introduces AI Agents to Enhance Home Care Efficiency
Cera launches AI agents to improve home care efficiency, addressing recruitment and patient care challenges. 🤖🏥
January 8, 2026
A strategic framework for digital and sustainable transformation in allergy care: An EAACI position paper.
Digital health innovations in allergy care: A framework for sustainability and improved patient outcomes. 🌍📱
January 8, 2026
Transforming Emergency Care Through Telemedicine: A Narrative Review.
Telemedicine revolutionizes emergency care, enhancing access and outcomes. Key challenges remain. 📈💻
January 8, 2026
Artificial intelligence in gynecologic oncology: A cautionary look in the Indian context.
AI in gynecologic oncology shows promise but raises concerns. Caution is advised in its rapid evolution. 🤖⚖️
January 8, 2026
Gender Disparities in NHS Digital Transformation
Gender disparities in NHS digital transformation may widen workforce inequalities. Female clinicians face unique challenges with AI tools. ⚕️💻
January 7, 2026
Cost-effectiveness of opportunistic osteoporosis screening using artificial-intelligence assisted chest radiographs in Japan.
AI-assisted chest X-rays for osteoporosis screening in Japan: Cost per QALY is ¥189,713, well below ¥5 million threshold. 📊💡
January 7, 2026
Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives.
Exploring IBD: 30%-40% of patients resist current treatments. New strategies like AI and microbiota interventions show promise. 🌱💊
January 7, 2026